TX · State regulatory reference
Texas.
Permissive
Among the more permissive jurisdictions for peptide therapy. Multiple 503A compounding pharmacies operate openly. Texas Medical Board has not pursued the visible enforcement pattern that California has. Texas was an early adopter of broad telehealth authorization (SB 670, 2019).
Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
Broad telehealth allowance. Initial encounters generally permitted via synchronous audio-video.
Compounding
Active 503A and 503B presence; Houston in particular hosts multiple outsourcing facilities serving peptide markets.
Sources